GB0021484D0 - Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases - Google Patents

Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases

Info

Publication number
GB0021484D0
GB0021484D0 GBGB0021484.1A GB0021484A GB0021484D0 GB 0021484 D0 GB0021484 D0 GB 0021484D0 GB 0021484 A GB0021484 A GB 0021484A GB 0021484 D0 GB0021484 D0 GB 0021484D0
Authority
GB
United Kingdom
Prior art keywords
airway diseases
positively influence
identifying substances
chronic inflammatory
inflammatory conditions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0021484.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BOEHRINGER INGELHEIM PHARMA
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
BOEHRINGER INGELHEIM PHARMA
Boehringer Ingelheim Pharma GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BOEHRINGER INGELHEIM PHARMA, Boehringer Ingelheim Pharma GmbH and Co KG filed Critical BOEHRINGER INGELHEIM PHARMA
Priority to GBGB0021484.1A priority Critical patent/GB0021484D0/en
Publication of GB0021484D0 publication Critical patent/GB0021484D0/en
Priority to AU2001282118A priority patent/AU2001282118A1/en
Priority to PCT/EP2001/009727 priority patent/WO2002018938A1/en
Priority to JP2002523607A priority patent/JP2004507262A/en
Priority to EP01960700A priority patent/EP1315963A1/en
Priority to MXPA03001506A priority patent/MXPA03001506A/en
Priority to CA002418506A priority patent/CA2418506C/en
Priority to US09/944,807 priority patent/US6773895B2/en
Priority to US10/874,015 priority patent/US20040253630A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/12—Pulmonary diseases

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Public Health (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
GBGB0021484.1A 2000-09-01 2000-09-01 Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases Ceased GB0021484D0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
GBGB0021484.1A GB0021484D0 (en) 2000-09-01 2000-09-01 Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases
AU2001282118A AU2001282118A1 (en) 2000-09-01 2001-08-23 Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases
PCT/EP2001/009727 WO2002018938A1 (en) 2000-09-01 2001-08-23 Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases
JP2002523607A JP2004507262A (en) 2000-09-01 2001-08-23 Methods for identifying substances that clearly affect the inflammatory state of chronic inflammatory airway disease
EP01960700A EP1315963A1 (en) 2000-09-01 2001-08-23 Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases
MXPA03001506A MXPA03001506A (en) 2000-09-01 2001-08-23 Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases.
CA002418506A CA2418506C (en) 2000-09-01 2001-08-23 Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases
US09/944,807 US6773895B2 (en) 2000-09-01 2001-08-31 Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases
US10/874,015 US20040253630A1 (en) 2000-09-01 2004-06-22 Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0021484.1A GB0021484D0 (en) 2000-09-01 2000-09-01 Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases

Publications (1)

Publication Number Publication Date
GB0021484D0 true GB0021484D0 (en) 2000-10-18

Family

ID=9898663

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0021484.1A Ceased GB0021484D0 (en) 2000-09-01 2000-09-01 Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases

Country Status (7)

Country Link
EP (1) EP1315963A1 (en)
JP (1) JP2004507262A (en)
AU (1) AU2001282118A1 (en)
CA (1) CA2418506C (en)
GB (1) GB0021484D0 (en)
MX (1) MXPA03001506A (en)
WO (1) WO2002018938A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002013845A2 (en) * 2000-08-18 2002-02-21 Novartis Ag Inflammation related g-protein coupled receptor
EP1448600A4 (en) 2001-09-07 2004-12-22 Bristol Myers Squibb Co Polynucleotide encoding a novel human g-protein coupled receptor, hgprbmy39
US6902902B2 (en) 2001-11-27 2005-06-07 Arena Pharmaceuticals, Inc. Human G protein-coupled receptors and modulators thereof for the treatment of metabolic-related disorders
WO2003082314A2 (en) * 2002-04-03 2003-10-09 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with n-formyl peptide receptor like 1 (fprl1)
US7189524B1 (en) 2002-11-25 2007-03-13 Amgen, Inc. Receptor ligands and methods of modulating receptors
WO2004071394A2 (en) * 2003-02-13 2004-08-26 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with hm74
EP1603585A2 (en) 2003-03-14 2005-12-14 Bristol-Myers Squibb Company Polynucleotide encoding a novel human g-protein coupled receptor variant of hm74, hgprbmy74
CN1921845A (en) * 2004-02-20 2007-02-28 安万特药物公司 Furosemide derivatives as modulators of HM74 and their use for the treatment of inflammation
BRPI0507916A (en) * 2004-02-20 2007-07-10 Aventis Pharma Inc hm74 oxidecahydronaphthalene modulators
CA2628401A1 (en) * 2005-12-07 2007-06-14 Boehringer Ingelheim International Gmbh Treatment and diagnostics of inflammatory diseases
JP6151129B2 (en) * 2013-08-19 2017-06-21 テルモ株式会社 Fibrotic agent
JP6210794B2 (en) * 2013-08-19 2017-10-11 テルモ株式会社 Fibrotic agent
PL3658589T3 (en) 2017-07-26 2024-03-18 Forty Seven, Inc. Anti-sirp-alpha antibodies and related methods

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5648344A (en) * 1990-07-30 1997-07-15 Glycomed Incorporated Methods of treating inflammation using selection binding compounds
WO1992002822A1 (en) * 1990-08-06 1992-02-20 Cetus Corporation Methods for the identification of cytokine convertase inhibitors
WO1994025570A1 (en) * 1993-04-23 1994-11-10 Sloan-Kettering Institute For Cancer Research Method for screening for targets for anti-inflammatory or anti-allergic agents
US6160088A (en) * 1998-07-29 2000-12-12 Sloan-Kettering Institute For Cancer KDEL receptor inhibitors
WO2000031261A2 (en) * 1998-11-25 2000-06-02 Cadus Pharmaceutical Corporation Methods and compositions for identifying effectors of the formyl peptide receptor like-1 (fprl-1) receptor
EP1137947B1 (en) * 1998-12-11 2005-10-19 Children's Hospital Medical Center Method for determining asthma susceptibility
WO2002013845A2 (en) * 2000-08-18 2002-02-21 Novartis Ag Inflammation related g-protein coupled receptor

Also Published As

Publication number Publication date
MXPA03001506A (en) 2003-06-09
WO2002018938A1 (en) 2002-03-07
AU2001282118A1 (en) 2002-03-13
JP2004507262A (en) 2004-03-11
EP1315963A1 (en) 2003-06-04
CA2418506A1 (en) 2002-03-07
CA2418506C (en) 2009-04-28

Similar Documents

Publication Publication Date Title
IL163600A0 (en) Methods for detection of genetic disorders
DE60211325D1 (en) METHOD FOR DETECTING THE BROKEN VALVE
GB0021484D0 (en) Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases
AU2003250829A1 (en) System and method for the automatic detection of the expiratory flow limitation
GB0019290D0 (en) Methods for inducing apolipoprotein E secretion
DE60104073D1 (en) Chromatographic separation method
HK1092874A1 (en) Method of determining partial discharge and system for determining partial discharge
EP1662995A4 (en) Method for analyzing airway disorders
AU1183902A (en) Methods for parallel measurement of genetic variations
EP1450820A4 (en) Method for treating or preventing inflammatory diseases
AU2003220034A1 (en) An early detection marker for chronic inflammatory associated diseases
AU2003227388A1 (en) Method for determining the anxiety level of a human being
HK1053844A1 (en) Method of identifying inhibitors of tie-2
EP1349961A4 (en) Methods for determining the biological effects of compounds on gene expression
AU2002221950A1 (en) Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases
AU2002240840A1 (en) Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases
AU6346901A (en) Method of detecting inflammatory lung disorders
HUP0400066A3 (en) Method and means for detecting gluten-induced diseases
DE50114429D1 (en) METHOD FOR INCREASING THE BRAKING EFFECT
AU2003224012A8 (en) Method and system for determining absolute mrna quantities
SG123633A1 (en) System and method for detecting of pulmonary diseases
GB0029539D0 (en) Method for identifying modulatorss of transcription
PL371585A1 (en) Method for manufacture of sertindole
WO2002052269A3 (en) Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases
HK1080855A1 (en) Method for manufacture of sertindole

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)